We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
This document contains a synopsis of causation occurring in psoriasis.
You must tell DVLA if you have arthritis and use special controls for driving - download the correct form to let them know
We are considering making Dovonex Psoriasis 50 microgram/g Ointment available to buy from pharmacies. We always want to involve the public and healthcare professionals in decisions that affect them. We want to know what you think about this change.
The characteristics, symptoms and epidemiology of parvovirus B19 (also known as slapped cheek syndrome, fifth disease, or erythma infectiosum).
Photosensitivity reactions are known side effects of methotrexate treatment and can be severe. Patients should be advised to take precautions to protect their skin in the sun.
Information from the National Health Service on conditions, treatments, local services and healthy living
Protocol, questionnaire and quarterly return form for the enhanced surveillance of post-herpetic neuralgia (PHN), a complication of shingles.
Public Assessment Report (PAR) reviewing available safety data for topical steroid withdrawal reactions, which have been associated with topical corticosteroids.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).